Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C

• Main Authors: Ping Zhu (Author), Shi-You Li (Author), Jin Ding (Author), Zhou Fei (Author), Sheng-Nan Sun (Author), Zhao-Hui Zheng (Author), Ding Wei (Author), Jun Jiang (Author), Jin-Lin Miao (Author), San-Zhong Li (Author), Xing Luo (Author), Kui Zhang (Author), Bin Wang (Author), Kun Zhang (Author), Su Pu (Author), Qian-Ting Wang (Author), Xin-Yue Zhang (Author), Gao-Liu Wen (Author), Jun O. Liu (Author), John Thomas August (Author), Huijie Bian (Author), Zhi-Nan Chen (Author), You-Wen He (Author)
• Format: Book
• Published: Elsevier, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Glioblastoma (GBM) is a lethal cancer with limited therapeutic options. Dendritic cell (DC)-based cancer vaccines provide a promising approach for GBM treatment. Clinical studies suggest that other immunotherapeutic agents may be combined with DC vaccines to further enhance antitumor activity. Here,...